Aardvark Therapeutics, Inc. Common Stock (AARD) vs Caribou Biosciences, Inc. (CRBU)
A side-by-side comparison of Aardvark Therapeutics, Inc. Common Stock and Caribou Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AARD
Aardvark Therapeutics, Inc. Common Stock
$5.04HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
CRBU
Caribou Biosciences, Inc.
$1.14HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — AARD vs CRBU
growth of $100 · dividends reinvested · last 2yAARD -63.5% (-39.6%/yr)CRBU -9.2% (-4.7%/yr)CRBU compounded faster over this window
AARD CRBU
AARD vs CRBU: by the numbers
- •CRBU is the larger company ($113M vs $110M market cap).
- •Both run net losses; AARD's is the smaller (0.00% vs -1030.42% net margin).
Metrics side by side
Valuation
| Metric | AARD | CRBU |
|---|---|---|
| P/S ratio | N/A | 11.22 |
| P/B ratio | 1.47 | 1.15 |
Profitability
| Metric | AARD | CRBU |
|---|---|---|
| Gross margin | 0.00% | 67.34% |
| Operating margin | 0.00% | -1220.49% |
| Net margin | 0.00% | -1030.42% |
| ROE | -93.44% | -105.40% |
| ROIC | -97.99% | -87.72% |
Growth (annualized)
| Metric | AARD | CRBU |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -2.03% |
| Total return CAGR (5Y) | N/A | -44.43% |
Go deeper
Dig into the metrics
Aardvark Therapeutics, Inc. Common Stock ROECaribou Biosciences ROEAardvark Therapeutics, Inc. Common Stock operating marginCaribou Biosciences operating marginAardvark Therapeutics, Inc. Common Stock revenue growthCaribou Biosciences revenue growthAardvark Therapeutics, Inc. Common Stock free cash flowCaribou Biosciences free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.